Clinical Pharmacy 2020 invites all the participants all around the world to attend 3rd Asian Congress on Clinical Pharmacy and Business Management scheduled on May 13-14, 2020 at Singapore, which includes prompt Keynote Presentations, Special Sessions, Workshop, Symposium, Oral talks, Poster Presentations, Sponsors/Exhibitors and Young Research Forum (YRF).
Clinical Pharmacy 2020 is a global event to discuss and learn more about Clinical Pharmacy and Business Management. The conference aims to bring together leading academic scientists, researchers, and research scholars to exchange and share their experiences and research results on all aspects of Clinical Pharmacy. It also provides a premier interdisciplinary platform for researchers, practitioners, and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Clinical and Hospital Pharma Education.
Abstract Submission and Registration
The title should be in Sentence case.
Should write name of the author and co-authors (if any).
You must provide your full name, affiliation (degree, institution/ company/ University name, address,contact number and email address).
Short biography of the author (limited to 100 words).
They must be submitted before the deadlines.
All the abstracts will be reviewed by the committee and you will get a email within 24-48 hours after submission of your abstract.
All the accepted abstracts will be published in the conference proceeding books.
Abstract Submission Link: https://hospital-clinicalpharmacy.alliedacademies.com/abstract-submission
Session 1: Pharmaceutical Research and Drug Development
Medication development is the way of introducing a new pharmaceutical drug to the market once a lead compound has been recognized through the procedure of drug revelation. It includes pre-clinical research on microorganisms and creatures, petitioning for administrative status.
· Drug Discovery
· Bio-engineering in Pharmaceutical Industry
· Engineering Models in Biomedicine
· Quality Control and Quality Assurance
· Active Pharmaceutical Ingredients
Session 2: Clinical Pharmacy and Pharmacy Practices
Clinical pharmacy and pharmacy practice play important roles in clinical trials and clinical research. In recent years pharmacist role in clinical research and patient care has improved significantly and they play active role in designing and modifying drug therapies. This session focuses on the recent advancements in clinical research and pharmacy practice.
Session 3: Pharma Business Management
Pharma Business Management will be a multidisciplinary gathering and present of areas such as Pharmaceutical Research, Social Sciences, Economics, New Technology’s, Education and policies. The forum of Scientists, students and researchers from all over of the globe, come together to discuss about the future science & Technology. Each session of the conference will be included with expert lectures, poster and discussions, join us to design sustainable development processes, innovations by which and how these strategies drive new policies, advances the business and human health protection.
· Brand Management
· Family Firms
· Open Innovation
Session 4: Hospital Pharmacy and Health Management
Hospital pharmacists are usually found within the premises of a hospital.
Hospital pharmacists usually stock a larger range of medications, including
more specialized and investigational medications, which would be feasible
in the community setting. Hospital pharmacists typically provide medications for hospitalized patients only and are not retail establishments. To
support this practice it is essential that there be an established national
framework of quality standards and guidelines of the prescribed drugs. Pharmacy teams
ensure public health services and interventions are evidence-based as far as
possible, in order to ensure consistency, high-quality services and optimum
outcomes for population health from public health services and interventions
delivered through the pharmacy.
Session 5: Clinical Pharmacology and Toxicology
Clinical pharmacology connects the relation between medical practice and laboratory science. The main objective is to promote the safety of prescription, maximize the drug effects and minimize the side effects of the drugs. It is important that there are associations with pharmacists skilled in areas of drug information, medication safety and other aspects of pharmacy practice related to clinical pharmacology. Clinical pharmacologists must have access to enough outpatients for clinical care, teaching and education, and researchers will be supervised by medical specialists. Their responsibilities to patients include, but are not limited to analysing adverse drug effects, therapeutics and toxicology including reproductive toxicology, cardiovascular risks.
· Properties of drugs and their actions
· Molecule-receptor interactions
· Study of drug actions
· Use of drugs as therapeutic agents in medicine
· Adverse effects of drugs
· Study of drug safety
Session 6: Clinical Trials
Clinical trials are observations on clinical research. Prospective behavioural research studies on human beings to answer particular queries on biomedical or behavioural interventions. This creates data on safety and efficacy. In master protocol, multiple experimental treatments are tested in only one trail. Clinical trial protocol is used to describe and supervise the trail. This protocol contains a definite study plan to assure safety and health trails and to give a correct template for trail conduct to inspector. A clinical trial involves new drugs are classified into five phases. Each phase of the drug compliance is treated as a separate clinical trial. The drug-development process will move forward through all four phases. Phase 0 – pharmacodynamics and pharmacokinetics in humans (testing within 10 to 15 people). Phase 1 – screening for safety (testing within a small group of people 20 to 80 people). Phase 2 – establishing the efficacy of the drug (testing with a larger group of people 100 to 300 people). Phase 3 – final confirmation of safety and efficacy (testing with a large group of people 1000 to 3000 people). Phase 4 –safety studies during sales (post marketing studies describes additional information including the treatments risk, benefits, and optimal use).
Session 7: Pharmacogenomics and Pharmacovigilance
It is the study of how genes affect a person’s response to drugs. Pharmacogenomics combines with pharmacology and genomics to develop effective and safe medications and doses that will be tailored to a person’s genetic ability. Pharmacogenomics use is currently quite limited, but new approaches are under study in clinical trials. It aims to optimize patient management by synthesizing drugs and customizing based on genetic variations in drug response. Pharmacogenomics approaches are widely expected to bring about a “revolution” in medicine.
· Applications of Pharmacogenomics
· Biomarkers in Drug Labelling
· Drug Metabolizing Enzymes
· Genome Sequencing
Session 8: Pre-formulation & Formulation Aspects
The physio-chemical and mechanical properties of the drug are indispensable in the preparation of the drug in pre-formulation studies. In dealing with protein pre-formulation, it is important to consider the solution behavioral of a given protein under different physiological conditions. While formulating the drug, physio-chemical properties like particle size, polymorphism`, pH and solubility are should be taken into consideration as they impact bio availability and the activity of a drug. The formulation should ensure that the dosage should have a uniform appearance, acceptable taste and capsule disintegration properties.
· Freeze drying aspects
· Pre-Formulation in Drug Development
· Drug Formulation Considerations
· Major Challenges in Drug Development
· Physiological Drug Environment
· Hot melt extrusion
· Preclinical Formulations
· Biopharmaceutical Support in Formulation
· Intracellular drug delivery systems
· Challenges in drug development
· Physiochemical properties of a drug
Session 9: Drug Discovery in Preclinical Research
The chief impartial of pre-clinical studies is to define the safe dose for first-in-man study and assess a product's safety profile. Pre-clinical development also recognised as pre-clinical studies and non-clinical studies .In the drug development, preclinical development, is a phase study which prior to earlier clinical trials can begin, and during which important possibility, iterative testing and drug safety data is composed. Generally, only one in every 5,000 compounds that arrives drug discovery to the stage of pre-clinical development befits as an approved drug. These pre-clinical studies involve local toxicity studies such as acute, sub-acute, chronic toxicity studies and systemic toxicity studies such as genotoxicity and carcinogenicity studies.
· Developing pharmacological profile of the drug
· Pre-clinical research leading to clinical trials
· The preclinical Development Process
· In-vitro and In-vivo studies
Session 10: Clinical Drug Development and Therapeutics
Drug development is the process in which a new drug comes into the market once a lead compound has been identified through various process. Drug design mostly referred to as rational drug design or simply rational design, where the process of searching new medications are based on the knowledge of a biological target. The drug is a small organic molecule which plays a role to activate or inhibit the function of a biomolecule such as a protein, that in turn results in a therapeutic benefit to the patient. Basically, drug design involves the design of molecules those are complementary in shape & charge to the biomolecular target with which they can interact and as a result will bind to it. A generic drug is a drug which is equivalent to a brand-name product in dosage, quality, performance, strength, route of administration, and intended of useage. In the stages of drug development research, the preclinical development initiates before clinical trials can begin, and during which important feasibility, iterative testing & drug safety data are collected.
Lead Discovery Methods
· Advanced Technologies Involved in Drug Discovery
· Preclinical Research
· Clinical Research
· FDA Post-Market Safety Monitoring
Session 11: Healthcare and Hospital Management
A hospital is an organization where the understanding of treatment is being done with the particular staff. The best-known clinic is the general doctor's facilities, which is having a crisis division. Healthcare Management offers many routes one can take. Healthcare industry broadly comprises of Medical Device industry, Pharmaceutical industry and hospitals.
· Patient Safety
· Healthcare and Medical Devices
· Healthcare and Diagnostics
Session 12: Entrepreneur Drug Investment Meet
An individual who puts his/her own specific money in a Pioneering Association. At first, a term used to depict theorists on Broadway shows up, "Holy Messenger" presently insinuates any person who puts his or her money in an innovative association. (Co) founders are people related with the hidden dispatch of new organizations. Anyone can be a prime supporter, and a present association can moreover be a kindred sponsor, yet the most notable prime supporters are originator CEOs, engineers, software engineers, website specialists, site masters, and others connected with the ground dimension of another, routinely experience. Wound Care gives wonderful streets to Investors searching for endeavour openings and growing their business horizons. Our congress has individuals from in excess of forty countries and attracts an influencing mix of enlightening researchers, specialists, and people who have busy with different pieces of progressions in Wound Care and Regenerative Medicine examination thus giving heaps of frameworks organization openings and new information.
· Financial markets
· Classical and neoclassical economists
· Research and development efforts
· Investment strategy
· Types of financial investment
Session 13: Drug Toxicity and Drug Safety
Drug toxicity can be defined as the level of damage that a drug can cause to an organism. The toxic effects of a drug are dose-dependent and can affect an entire system as in the CNS or a specific organ such as liver. Drug toxicity usually occurs at doses that exceed the therapeutic efficacy of a drug. However, toxic and therapeutic effects can occur simultaneously. Drug absorption is set by the drug’s chemistry properties, formulation, and route of administration. In spite of the route of administration, medicine should be in answer to be absorbed. Thus, solid dosage forms should be able to disintegrate and disaggregate. And Route of Administration in medicine and pharmacological medicine is that the path by that a drug, fluid, poison, or alternative substance is taken into the body. Routes of administration square measure typically classified by the placement at that the substance is applied. Common examples embody oral and endogenous administration.
· Basic principles
· Testing methods
· Dose response complexities
Session 14: Adverse Drug Reactions
It occurs if a drug dose is too high (Overdose reaction), or if the person is unusually sensitive to the drug. Every drug has the potential for adverse drug reactions, so risk-benefit analysis (analyzing the likelihood of benefit vs. risk of ADRs) is necessary whenever a drug is prescribed.
· Allergic drug reactions
· Pseudo allergic adverse drug reactions
· Intolerance adverse drug reactions
· Idiosyncratic adverse drug reactions
Session 15: Patient and Drug Safety
Drug absorption is set by the drug’s chemistry properties, formulation, and route of administration. Dosage forms consisting of the drug and alternative ingredients measures developed to lean by numerous routes. In spite of the route of administration, medicine should be in answer to be absorbed. Thus, solid dosage form should be able to disintegrate and disaggregate and Route of Administration in medicine and pharmacological medicine is that the path by that a drug, fluid, poison or alternative substance is taken into the body. Routes of administration square measure typically classified by the placement at that the substance is applied. Common examples embody oral and endogenous administration. Effects of Disease on Drug disposition refer to all processes concerned within the absorption, distribution metabolism and excretion of medication in an exceedingly living organism.
Mechanism of action
· Available Drugs
· Side Effects
Session 16: Oncology and Drug Therapy
Oncology is a branch of arrangements with tumours. Integrative oncology deals with the brain, body, and soul. That is the reason numerous experts, including medicinal specialists, have grasped the quickly extending field of integrative oncology, which merges the best of customary and option medications. The science of clinical trials in oncology evolved to include phase I dose? finding trials, phase II studies to establish efficacy in a single tumour type, phase III trials comparing standards of care with potential advances in care, and phase IV studies to extend safety and activity data in a post? marketing scenario. Immuno-oncology treatments enact our invulnerable framework, making it ready to perceive growth cells and destroy them. Since tumour cells are altogether different from ordinary cells in the body, the resistant framework attacks them when it can remember them. Neuro-oncology assesses and treats individuals with essential and optional tumours of the cerebrum, spinal line, and the layers encompassing the mind and spinal rope (meninges).
Importance & Scope:
The pharmacist works in management with the doctors for the patient healthcare. Clinical pharmacists have wide education in the biomedical, pharmaceutical, and clinical sciences. Clinical Pharmacy consists of all the services accomplished by pharmacists practicing in hospitals, community pharmacies, nursing homes, home-based care services, clinics and any other setting wherever medicines are prescribed and used. The term "clinical" does not necessarily suggest an action implemented in a hospital setting. It defines that the type of activity is connected to the health of the patients. This suggests that community pharmacists and hospital pharmacists both can accomplish clinical pharmacy activities.
Clinical Pharmacy 2020 welcomes attendees, presenters, and exhibitors from all over the world to gather in arena. The theme of this year’s Conference is “Innovative advancements in global clinical research and clinical trials” which will provide a worldwide platform for discussion of present and future challenges in Clinical Pharmacy, pharmacy education and expertise meeting. World-leading health practitioners, clinicians, educators, and researchers will present cutting-edge and practical clinical techniques based upon broadly accepted evidence and will introduce new and emerging research.